|
US5869079A
(en)
*
|
1995-06-02 |
1999-02-09 |
Oculex Pharmaceuticals, Inc. |
Formulation for controlled release of drugs by combining hydrophilic and hydrophobic agents
|
|
US20060280774A1
(en)
*
|
1995-06-02 |
2006-12-14 |
Allergan, Inc. |
Compositions and methods for treating glaucoma
|
|
US6117643A
(en)
*
|
1997-11-25 |
2000-09-12 |
Ut Battelle, Llc |
Bioluminescent bioreporter integrated circuit
|
|
EP1154691A4
(de)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Gezielte transsklerale gesteuerte wirkstoffabgabe an die retina und choroidae
|
|
US6217895B1
(en)
|
1999-03-22 |
2001-04-17 |
Control Delivery Systems |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
US20040121014A1
(en)
*
|
1999-03-22 |
2004-06-24 |
Control Delivery Systems, Inc. |
Method for treating and/or preventing retinal diseases with sustained release corticosteroids
|
|
ATE414494T1
(de)
|
1999-10-21 |
2008-12-15 |
Alcon Inc |
Medikamentenzuführeinrichtung
|
|
US7943162B2
(en)
*
|
1999-10-21 |
2011-05-17 |
Alcon, Inc. |
Drug delivery device
|
|
US6416777B1
(en)
|
1999-10-21 |
2002-07-09 |
Alcon Universal Ltd. |
Ophthalmic drug delivery device
|
|
ES2240180T3
(es)
|
1999-10-21 |
2005-10-16 |
Alcon Inc. |
Administracion sub-tenon de medicamentos.
|
|
US6331313B1
(en)
*
|
1999-10-22 |
2001-12-18 |
Oculex Pharmaceticals, Inc. |
Controlled-release biocompatible ocular drug delivery implant devices and methods
|
|
US20040208910A1
(en)
*
|
2000-04-26 |
2004-10-21 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of adrenergic agents
|
|
US20040115268A1
(en)
*
|
2000-04-26 |
2004-06-17 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
US20040175410A1
(en)
*
|
2000-04-26 |
2004-09-09 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
US6375972B1
(en)
|
2000-04-26 |
2002-04-23 |
Control Delivery Systems, Inc. |
Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
|
|
US6726918B1
(en)
|
2000-07-05 |
2004-04-27 |
Oculex Pharmaceuticals, Inc. |
Methods for treating inflammation-mediated conditions of the eye
|
|
USRE44145E1
(en)
|
2000-07-07 |
2013-04-09 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Preparation of hydrophilic pressure sensitive adhesives having optimized adhesive properties
|
|
US20050074747A1
(en)
*
|
2000-09-08 |
2005-04-07 |
Wadih Arap |
Biopanning and rapid analysis of selective interactive ligands (brasil)
|
|
US20040170955A1
(en)
*
|
2000-09-08 |
2004-09-02 |
Wadih Arap |
Human and mouse targeting peptides identified by phage display
|
|
US7452964B2
(en)
*
|
2001-09-07 |
2008-11-18 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides against placenta and adipose tissues
|
|
US7420030B2
(en)
*
|
2000-09-08 |
2008-09-02 |
The Board Of Regents Of The University Of Texas System |
Aminopeptidase A (APA) targeting peptides for the treatment of cancer
|
|
AR031880A1
(es)
*
|
2000-11-03 |
2003-10-08 |
Control Delivery Systems |
Dispositivo de liberacion sustentada implantable para administrar localmente un medicamento
|
|
AU2002236495B2
(en)
*
|
2000-11-29 |
2006-05-11 |
Allergan, Inc. |
Intraocular implants for preventing transplant rejection in the eye
|
|
WO2002056863A2
(en)
|
2000-12-29 |
2002-07-25 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices
|
|
EP1847255A3
(de)
*
|
2001-01-03 |
2009-03-04 |
Bausch & Lomb Incorporated |
Vorrichtung zur verzögerten Freigabe von Arzneimitteln mit beschichteten Kernen
|
|
US6964781B2
(en)
*
|
2001-01-03 |
2005-11-15 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with prefabricated permeable plugs
|
|
EP1404295B1
(de)
*
|
2001-01-03 |
2007-10-10 |
Bausch & Lomb Incorporated |
Vorrichtungen zur verzögerten wirkstofffreisetzung mit beschichteten medikamentenkernen
|
|
US6756058B2
(en)
|
2001-01-03 |
2004-06-29 |
Bausch & Lomb Incorporated |
Sustained release drug delivery devices with multiple agents
|
|
WO2002058667A2
(en)
*
|
2001-01-26 |
2002-08-01 |
Bausch & Lomb Incorporated |
Improved process for the production of sustained release drug delivery devices
|
|
US6713081B2
(en)
*
|
2001-03-15 |
2004-03-30 |
The United States Of America As Represented By The Department Of Health And Human Services |
Ocular therapeutic agent delivery devices and methods for making and using such devices
|
|
US7431710B2
(en)
|
2002-04-08 |
2008-10-07 |
Glaukos Corporation |
Ocular implants with anchors and methods thereof
|
|
US8206738B2
(en)
*
|
2001-05-01 |
2012-06-26 |
Corium International, Inc. |
Hydrogel compositions with an erodible backing member
|
|
RU2276998C2
(ru)
*
|
2001-05-01 |
2006-05-27 |
Институт Нефтехимического Синтеза Имени А.В. Топчиева Российской Академии Наук |
Гидрогелевые композиции
|
|
CA2447302C
(en)
*
|
2001-05-01 |
2008-07-29 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Two-phase, water-absorbent bioadhesive composition
|
|
US20050215727A1
(en)
|
2001-05-01 |
2005-09-29 |
Corium |
Water-absorbent adhesive compositions and associated methods of manufacture and use
|
|
US8840918B2
(en)
|
2001-05-01 |
2014-09-23 |
A. V. Topchiev Institute of Petrochemical Synthesis, Russian Academy of Sciences |
Hydrogel compositions for tooth whitening
|
|
US20050113510A1
(en)
|
2001-05-01 |
2005-05-26 |
Feldstein Mikhail M. |
Method of preparing polymeric adhesive compositions utilizing the mechanism of interaction between the polymer components
|
|
US8541021B2
(en)
|
2001-05-01 |
2013-09-24 |
A.V. Topchiev Institute Of Petrochemical Synthesis |
Hydrogel compositions demonstrating phase separation on contact with aqueous media
|
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
|
JP4677538B2
(ja)
*
|
2001-06-12 |
2011-04-27 |
ジョンズ ホプキンズ ユニヴァーシティ スクール オヴ メディシン |
眼内薬物送達のためのリザーバデバイス
|
|
CA2454357A1
(en)
*
|
2001-07-18 |
2003-01-30 |
Wadih Arap |
An anti-angiogenic state in mice and humans with retinal photoreceptor cell degeneration
|
|
DE60217679T2
(de)
|
2001-07-23 |
2007-10-25 |
Alcon Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
EP1385452B1
(de)
*
|
2001-07-23 |
2006-09-13 |
Alcon, Inc. |
Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
|
|
US7749528B2
(en)
*
|
2001-08-29 |
2010-07-06 |
Ricardo Azevedo Pontes De Carvalho |
Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
|
|
US7195774B2
(en)
|
2001-08-29 |
2007-03-27 |
Carvalho Ricardo Azevedo Ponte |
Implantable and sealable system for unidirectional delivery of therapeutic agents to tissues
|
|
US7671010B2
(en)
*
|
2002-08-30 |
2010-03-02 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20040048243A1
(en)
*
|
2001-09-07 |
2004-03-11 |
Wadih Arap |
Methods and compositions for in vitro targeting
|
|
US8507445B2
(en)
*
|
2001-09-07 |
2013-08-13 |
Board Of Regents, The University Of Texas System |
Compositions and methods of use of targeting peptides for diagnosis and therapy of human cancer
|
|
US20030158598A1
(en)
*
|
2001-09-17 |
2003-08-21 |
Control Delivery Systems, Inc. |
System for sustained-release delivery of anti-inflammatory agents from a coated medical device
|
|
EA006561B1
(ru)
*
|
2002-01-31 |
2006-02-24 |
Вестергор Франдсен А/С |
Ламинированный инсектицидный диспенсер
|
|
US20030229333A1
(en)
*
|
2002-02-22 |
2003-12-11 |
Control Delivery Systems, Inc. |
Methods for treating otic disorders
|
|
EP1482914B1
(de)
*
|
2002-03-11 |
2015-04-22 |
Novartis AG |
Implantierbare arzneimittelabgabevorrichtung fürs auge
|
|
JP5578388B2
(ja)
*
|
2002-04-18 |
2014-08-27 |
オプコ ファーマシューティカルズ、エルエルシー |
中枢神経システム及び／若しくは眼の細胞及び組織中の遺伝子の特異的阻害のための手段と方法
|
|
AU2003234294A1
(en)
*
|
2002-05-02 |
2003-11-17 |
Control Delivery Systems, Inc. |
Device and method for treating conditions of a joint
|
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
|
US8871241B2
(en)
|
2002-05-07 |
2014-10-28 |
Psivida Us, Inc. |
Injectable sustained release delivery devices
|
|
CN1658836A
(zh)
*
|
2002-05-07 |
2005-08-24 |
控制传输系统公司 |
形成药物传递装置的方法
|
|
CN100469776C
(zh)
|
2002-05-17 |
2009-03-18 |
奥特拉控股公司 |
白内障和其它眼病发展的改善
|
|
WO2004006890A1
(en)
*
|
2002-07-15 |
2004-01-22 |
Alcon, Inc. |
Non-polymeric lipophilic pharmaceutical implant compositions for intraocular use
|
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
|
US7148342B2
(en)
|
2002-07-24 |
2006-12-12 |
The Trustees Of The University Of Pennyslvania |
Compositions and methods for sirna inhibition of angiogenesis
|
|
AU2003301347A1
(en)
*
|
2002-10-17 |
2004-05-04 |
Control Delivery Systems, Inc. |
Methods for monitoring treatment of disease
|
|
AU2003287666A1
(en)
*
|
2002-11-13 |
2004-06-03 |
Control Delivery Systems, Inc. |
Systemic delivery of antiviral agents
|
|
CA2453013C
(en)
*
|
2002-12-13 |
2011-02-15 |
Gary W. Cleary |
Dermal, transdermal, mucosal or transmucosal ingredient delivery devices
|
|
JP2006513217A
(ja)
*
|
2002-12-20 |
2006-04-20 |
コントロール・デリバリー・システムズ・インコーポレイテッド |
眼内用途のためのステロイド組成物
|
|
US20050048099A1
(en)
|
2003-01-09 |
2005-03-03 |
Allergan, Inc. |
Ocular implant made by a double extrusion process
|
|
ATE477337T1
(de)
|
2003-01-16 |
2010-08-15 |
Univ Pennsylvania |
Zusammensetzungen und verfahren zur sirna-hemmung von icam-1
|
|
WO2004066980A2
(en)
*
|
2003-01-24 |
2004-08-12 |
Control Delivery Systems, Inc. |
Sustained release device and method for ocular delivery of carbonic anhydrase inhibitors
|
|
BRPI0406879B1
(pt)
*
|
2003-01-24 |
2015-12-22 |
Control Delivery Sys Inc |
dispositivo de liberação de droga de liberação sustentada
|
|
BRPI0406858A
(pt)
*
|
2003-01-24 |
2006-01-03 |
Control Delivery Sys Inc |
Liberação controlada de agentes altamente solúveis
|
|
WO2004066939A2
(en)
*
|
2003-01-27 |
2004-08-12 |
Sarnoff Corporation |
Controlled-release drug delivery system
|
|
US20060167435A1
(en)
*
|
2003-02-18 |
2006-07-27 |
Adamis Anthony P |
Transscleral drug delivery device and related methods
|
|
US9445901B2
(en)
*
|
2003-03-12 |
2016-09-20 |
Deger C. Tunc |
Prosthesis with sustained release analgesic
|
|
US20050261668A1
(en)
*
|
2003-03-28 |
2005-11-24 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US7037521B2
(en)
*
|
2003-03-28 |
2006-05-02 |
Bausch & Lomb Incorporated |
Using a laser for cutting a hole in a capsule for controlled drug delivery
|
|
US7589107B2
(en)
|
2003-05-19 |
2009-09-15 |
Othera Holding, Inc. |
Amelioration of vitrectomy-induced cataracts
|
|
US7825134B2
(en)
*
|
2003-05-19 |
2010-11-02 |
Othera Holding, Inc. |
Amelioration of cataracts, macular degeneration and other ophthalmic diseases
|
|
US7561916B2
(en)
|
2005-06-24 |
2009-07-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with indicator
|
|
US7850660B2
(en)
*
|
2003-12-19 |
2010-12-14 |
Ethicon Endo-Surgery, Inc. |
Implantable medical device with simultaneous attachment mechanism and method
|
|
US8715243B2
(en)
*
|
2003-06-16 |
2014-05-06 |
Ethicon Endo-Surgery, Inc. |
Injection port applier with downward force actuation
|
|
US7862546B2
(en)
*
|
2003-06-16 |
2011-01-04 |
Ethicon Endo-Surgery, Inc. |
Subcutaneous self attaching injection port with integral moveable retention members
|
|
US8491883B2
(en)
*
|
2003-06-27 |
2013-07-23 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of amyotrophic lateral sclerosis using umbilical derived cells
|
|
ES2564044T3
(es)
|
2003-06-27 |
2016-03-17 |
DePuy Synthes Products, Inc. |
Células posparto derivadas de tejido del cordón umbilical y métodos de preparación y uso de las mismas
|
|
US7875272B2
(en)
|
2003-06-27 |
2011-01-25 |
Ethicon, Incorporated |
Treatment of stroke and other acute neuraldegenerative disorders using postpartum derived cells
|
|
US8790637B2
(en)
*
|
2003-06-27 |
2014-07-29 |
DePuy Synthes Products, LLC |
Repair and regeneration of ocular tissue using postpartum-derived cells
|
|
AU2005322060B2
(en)
|
2003-06-27 |
2011-11-17 |
Ethicon Incorporated |
Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
|
|
US9592258B2
(en)
|
2003-06-27 |
2017-03-14 |
DePuy Synthes Products, Inc. |
Treatment of neurological injury by administration of human umbilical cord tissue-derived cells
|
|
US9572840B2
(en)
|
2003-06-27 |
2017-02-21 |
DePuy Synthes Products, Inc. |
Regeneration and repair of neural tissue using postpartum-derived cells
|
|
US8518390B2
(en)
|
2003-06-27 |
2013-08-27 |
Advanced Technologies And Regenerative Medicine, Llc |
Treatment of stroke and other acute neural degenerative disorders via intranasal administration of umbilical cord-derived cells
|
|
US20050054586A1
(en)
*
|
2003-06-30 |
2005-03-10 |
Bartels Stephen P. |
Treatment of ophthalmic disorders
|
|
US20040265356A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
WO2005007020A2
(en)
*
|
2003-07-03 |
2005-01-27 |
Corium International, Inc. |
Wound dressing, ingredient delivery device and iv hold-down, and method relating to same
|
|
KR20060082792A
(ko)
*
|
2003-07-10 |
2006-07-19 |
알콘, 인코퍼레이티드 |
안과용 약물 전달 장치
|
|
JP2007505932A
(ja)
*
|
2003-09-18 |
2007-03-15 |
マクサイト， インコーポレイテッド |
経強膜送達
|
|
PL1696822T3
(pl)
*
|
2003-11-13 |
2010-08-31 |
Psivida Inc |
Wstrzykiwane implanty o opóźnionym wydzielaniu mające matrycę rdzenia i powłokę podatne na erozję biologiczną
|
|
AU2004293105B2
(en)
|
2003-11-20 |
2010-09-09 |
Othera Holding, Inc. |
Amelioration of macular degeneration and other ophthalmic diseases
|
|
US20050148948A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Caputa Steven G. |
Sutureless ophthalmic drug delivery system and method
|
|
US8162897B2
(en)
*
|
2003-12-19 |
2012-04-24 |
Ethicon Endo-Surgery, Inc. |
Audible and tactile feedback
|
|
DE10360185A1
(de)
*
|
2003-12-20 |
2005-08-04 |
Max Wyssmann |
Vorrichtung zur gezielten, steuerbaren Abgabe oder zum Ansaugen einer Flüssigkeit oder einer viskosen Masse
|
|
US20050158365A1
(en)
|
2003-12-22 |
2005-07-21 |
David Watson |
Drug delivery device with mechanical locking mechanism
|
|
US7211272B2
(en)
*
|
2003-12-22 |
2007-05-01 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050137538A1
(en)
|
2003-12-22 |
2005-06-23 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
US20050136095A1
(en)
*
|
2003-12-22 |
2005-06-23 |
Brian Levy |
Drug delivery device with suture ring
|
|
US7976858B2
(en)
*
|
2004-01-13 |
2011-07-12 |
The Hospital For Special Surgery |
Drug delivery to a joint
|
|
CN101018541A
(zh)
*
|
2004-01-26 |
2007-08-15 |
普西维达公司 |
核酸基治疗药剂的受控和持续传输
|
|
EP1713450B1
(de)
|
2004-01-30 |
2021-10-06 |
Corium, Inc. |
Schnell auflösender film zur abgabe eines wirkstoffs
|
|
US20060018949A1
(en)
*
|
2004-04-07 |
2006-01-26 |
Bausch & Lomb Incorporated |
Injectable biodegradable drug delivery system
|
|
US20050244469A1
(en)
|
2004-04-30 |
2005-11-03 |
Allergan, Inc. |
Extended therapeutic effect ocular implant treatments
|
|
BRPI0511462A
(pt)
*
|
2004-05-25 |
2007-12-26 |
Othera Pharmaceuticals Inc |
medicamentos e pró-medicamentos óculo-seletivos
|
|
WO2006004795A2
(en)
|
2004-06-25 |
2006-01-12 |
The Johns Hopkins University |
Angiogenesis inhibitors
|
|
EP1765454B1
(de)
|
2004-07-02 |
2016-04-13 |
Mati Therapeutics Inc. |
Behandlungsmittelabgabevorrichtung für das auge
|
|
US20060110428A1
(en)
|
2004-07-02 |
2006-05-25 |
Eugene Dejuan |
Methods and devices for the treatment of ocular conditions
|
|
CN101039706A
(zh)
*
|
2004-08-05 |
2007-09-19 |
考里安国际公司 |
粘合剂组合物
|
|
US20060067978A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly(vinyl alcohol) drug delivery devices
|
|
US20060068012A1
(en)
*
|
2004-09-29 |
2006-03-30 |
Bausch & Lomb Incorporated |
Process for preparing poly (vinyl alcohol) drug delivery devices with humidity control
|
|
US20060067979A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Ophthalmic drug release device for multiple drug release
|
|
US20060067980A1
(en)
*
|
2004-09-30 |
2006-03-30 |
Bausch & Lomb Incorporated |
Capsule for encasing tablets for surgical insertion into the human body
|
|
US20060078592A1
(en)
*
|
2004-10-12 |
2006-04-13 |
Bausch & Lomb Incorporated |
Drug delivery systems
|
|
US20070276481A1
(en)
*
|
2004-12-08 |
2007-11-29 |
Renner Steven B |
Drug delivery device
|
|
US20060134162A1
(en)
*
|
2004-12-16 |
2006-06-22 |
Larson Christopher W |
Methods for fabricating a drug delivery device
|
|
WO2006083394A2
(en)
*
|
2004-12-21 |
2006-08-10 |
Ethicon, Inc. |
Postpartum cells derived from placental tissue, and methods of making, culturing, and using the same
|
|
US20060153815A1
(en)
*
|
2004-12-21 |
2006-07-13 |
Agnieszka Seyda |
Tissue engineering devices for the repair and regeneration of tissue
|
|
US20060171930A1
(en)
*
|
2004-12-21 |
2006-08-03 |
Agnieszka Seyda |
Postpartum cells derived from umbilical cord tissue, and methods of making, culturing, and using the same
|
|
US20060134175A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Stephen Bartels |
Drug eluting pharmaceutical delivery system for treatment of ocular disease and method of use
|
|
US20060134174A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
US20060135918A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Reusable drug delivery device
|
|
US20060134176A1
(en)
*
|
2004-12-22 |
2006-06-22 |
Bausch & Lomb Incorporated |
Pharmaceutical delivery system and method of use
|
|
WO2006071802A2
(en)
|
2004-12-23 |
2006-07-06 |
Ethicon Incorporated |
Treatment of stroke and other acute neural degenerative disorders using postpartum derived cells
|
|
WO2006086750A1
(en)
*
|
2005-02-09 |
2006-08-17 |
Macusight, Inc. |
Liquid formulations for treatment of diseases or conditions
|
|
US8663639B2
(en)
*
|
2005-02-09 |
2014-03-04 |
Santen Pharmaceutical Co., Ltd. |
Formulations for treating ocular diseases and conditions
|
|
JP2008533204A
(ja)
*
|
2005-03-21 |
2008-08-21 |
マクサイト， インコーポレイテッド |
病気又は症状の治療のためのドラッグ送達システム
|
|
CN101180086A
(zh)
*
|
2005-04-08 |
2008-05-14 |
苏尔莫迪克斯公司 |
用于经视网膜下递送的持续释放植入物
|
|
WO2006127592A2
(en)
*
|
2005-05-26 |
2006-11-30 |
Othera Pharmaceuticals, Inc. |
Use of hydroxylamine derivates for inhibiting vitrectomy-induced cataracts
|
|
US7651483B2
(en)
*
|
2005-06-24 |
2010-01-26 |
Ethicon Endo-Surgery, Inc. |
Injection port
|
|
US7918844B2
(en)
|
2005-06-24 |
2011-04-05 |
Ethicon Endo-Surgery, Inc. |
Applier for implantable medical device
|
|
US20060292202A1
(en)
*
|
2005-06-27 |
2006-12-28 |
Bausch & Lomb Incorporated |
Drug delivery device
|
|
CA2616537A1
(en)
|
2005-07-27 |
2007-02-01 |
University Of Florida Research Foundation, Inc. |
Small compounds that correct protein misfolding and uses thereof
|
|
US20070212397A1
(en)
*
|
2005-09-15 |
2007-09-13 |
Roth Daniel B |
Pharmaceutical delivery device and method for providing ocular treatment
|
|
PL1968594T3
(pl)
|
2005-11-29 |
2011-03-31 |
Glaxosmithkline Llc |
Leczenie zaburzeń neowaskularyzacyjnych oka, takich jak zwyrodnienie plamki żółtej, rozszerzenie naczyń siatkówki w zespole Hippla i Lindaua, zapalenie błony naczyniowej oka i obrzęk plamki
|
|
CN101374946B
(zh)
*
|
2005-12-16 |
2017-07-18 |
伊西康公司 |
用于在组织相容性不匹配的移植中抑制有害的免疫反应的组合物和方法
|
|
SG170789A1
(en)
*
|
2005-12-28 |
2011-05-30 |
Ethicon Inc |
Treatment of peripheral vascular disease using postpartum-derived cells
|
|
US9125906B2
(en)
|
2005-12-28 |
2015-09-08 |
DePuy Synthes Products, Inc. |
Treatment of peripheral vascular disease using umbilical cord tissue-derived cells
|
|
US20070178138A1
(en)
*
|
2006-02-01 |
2007-08-02 |
Allergan, Inc. |
Biodegradable non-opthalmic implants and related methods
|
|
US8492400B2
(en)
|
2006-02-09 |
2013-07-23 |
Santen Pharmaceutical Co., Ltd. |
Stable formulations, and methods of their preparation and use
|
|
US20070203190A1
(en)
*
|
2006-02-22 |
2007-08-30 |
Ghanshyam Patil |
Hydroxylamines and derivatives for the inhibition of complement activation
|
|
CN101443004B
(zh)
*
|
2006-03-23 |
2013-03-06 |
参天制药株式会社 |
用于与血管通透性有关的疾病或病症的制剂
|
|
EP2004172B1
(de)
|
2006-03-31 |
2019-03-13 |
Mati Therapeutics Inc. |
Wirkstofffreisetzungsstrukturen und zusammensetzungen für nasolacrimales system
|
|
US20090130212A1
(en)
*
|
2006-05-15 |
2009-05-21 |
Physical Pharmaceutica, Llc |
Composition and improved method for preparation of small particles
|
|
JP2009540011A
(ja)
*
|
2006-06-12 |
2009-11-19 |
エクセジェニックス、インク．ディー／ビー／エー オプコ ヘルス、インク． |
血管新生のｓｉＲＮＡ阻害のための組成物及び方法
|
|
US20070298073A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
US8802128B2
(en)
*
|
2006-06-23 |
2014-08-12 |
Allergan, Inc. |
Steroid-containing sustained release intraocular implants and related methods
|
|
ATE549022T1
(de)
|
2006-08-07 |
2012-03-15 |
Bausch & Lomb |
Behandlung von infektionen und deren folgeleiden mit kombinierten dissoziierten glocucorticoid- rezeptor-agonisten und antiinfektionswirkstoffen
|
|
WO2008027796A2
(en)
*
|
2006-08-31 |
2008-03-06 |
Bausch & Lomb Incorporated |
Compositions and methods for treating or preventing glaucoma or progression thereof
|
|
US7872118B2
(en)
*
|
2006-09-08 |
2011-01-18 |
Opko Ophthalmics, Llc |
siRNA and methods of manufacture
|
|
PL2061444T3
(pl)
*
|
2006-09-11 |
2011-09-30 |
Bausch & Lomb |
Kompozycje i sposoby leczenia, traktowania, kontrolowania, redukowania, łagodzenia lub zapobiegania alergii
|
|
US20110104159A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and methods for treating, controlling, reducing, ameliorating, or preventing allergy
|
|
US20110105559A1
(en)
*
|
2006-09-11 |
2011-05-05 |
Rohrs Brian R |
Compositions and Methods for Treating, Controlling, Reducing, Ameliorating, or Preventing Allergy
|
|
US20080145405A1
(en)
*
|
2006-12-15 |
2008-06-19 |
Kunzler Jay F |
Drug delivery devices
|
|
GB0713463D0
(en)
|
2007-07-11 |
2007-08-22 |
Btg Int Ltd |
Modulators of hypoxia inducible factor-1 and related uses
|
|
WO2008103613A2
(en)
|
2007-02-22 |
2008-08-28 |
Othera Holding, Inc. |
Hydroxylamine compounds and methods of their use
|
|
US20080265343A1
(en)
*
|
2007-04-26 |
2008-10-30 |
International Business Machines Corporation |
Field effect transistor with inverted t shaped gate electrode and methods for fabrication thereof
|
|
US20090042936A1
(en)
*
|
2007-08-10 |
2009-02-12 |
Ward Keith W |
Compositions and Methods for Treating or Controlling Anterior-Segment Inflammation
|
|
US20090087443A1
(en)
*
|
2007-09-27 |
2009-04-02 |
Bartels Stephen P |
Pharmacological Adjunctive Treatment Associated with Glaucoma Filtration Surgery
|
|
US8034329B2
(en)
*
|
2007-10-05 |
2011-10-11 |
Advanced Technologies And Regenerative Medicine, Llc |
Repair and regeneration of renal tissue using human umbilical cord tissue-derived cells
|
|
US20100152646A1
(en)
*
|
2008-02-29 |
2010-06-17 |
Reshma Girijavallabhan |
Intravitreal injection device and method
|
|
US9023063B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device having a safety cap
|
|
US9023062B2
(en)
|
2008-04-17 |
2015-05-05 |
Apollo Endosurgery, Inc. |
Implantable access port device and attachment system
|
|
US20090291073A1
(en)
*
|
2008-05-20 |
2009-11-26 |
Ward Keith W |
Compositions Comprising PKC-theta and Methods for Treating or Controlling Ophthalmic Disorders Using Same
|
|
US20100121441A1
(en)
*
|
2008-11-10 |
2010-05-13 |
Nabil Jabbour |
Surgical implant and method
|
|
US8470792B2
(en)
|
2008-12-04 |
2013-06-25 |
Opko Pharmaceuticals, Llc. |
Compositions and methods for selective inhibition of VEGF
|
|
WO2010077732A2
(en)
*
|
2008-12-09 |
2010-07-08 |
Aether Medical Llc |
Implantable analgesic
|
|
WO2010071863A1
(en)
*
|
2008-12-19 |
2010-06-24 |
Ethicon, Incorporated |
Regeneration and repair of neural tissue following injury
|
|
US10179900B2
(en)
*
|
2008-12-19 |
2019-01-15 |
DePuy Synthes Products, Inc. |
Conditioned media and methods of making a conditioned media
|
|
PT2379087E
(pt)
*
|
2008-12-19 |
2014-12-02 |
Depuy Synthes Products Llc |
Células derivadas do tecido do cordão umbilical para o tratamento da dor neuropática e espasticidade
|
|
BRPI0923068B1
(pt)
|
2008-12-19 |
2021-05-25 |
Advanced Technologies And Regenerative Medicine, Llc |
Uso de células derivadas de tecido de cordão umbilical para tratar um paciente tendo uma doença, distúrbio ou injúria pulmonar
|
|
AU2010204986B2
(en)
|
2009-01-14 |
2016-06-02 |
Corium International, Inc. |
Transdermal administration of tamsulosin
|
|
US8623395B2
(en)
|
2010-01-29 |
2014-01-07 |
Forsight Vision4, Inc. |
Implantable therapeutic device
|
|
CA3045436C
(en)
|
2009-01-29 |
2025-10-07 |
Forsight Vision4, Inc. |
ADMINISTRATION OF A MEDICATION IN THE POSTERIOR SEGMENT
|
|
WO2010093945A2
(en)
|
2009-02-13 |
2010-08-19 |
Glaukos Corporation |
Uveoscleral drug delivery implant and methods for implanting the same
|
|
CN102498204B
(zh)
*
|
2009-03-26 |
2015-02-04 |
德普伊新特斯产品有限责任公司 |
人脐带组织细胞作为用于阿尔茨海默病的疗法
|
|
US20110077270A1
(en)
*
|
2009-04-21 |
2011-03-31 |
Pfeffer Bruce A |
Compositions and Methods for Treating Ocular Inflammation with Lower Risk of Increased Intraocular Pressure
|
|
US8372036B2
(en)
*
|
2009-05-06 |
2013-02-12 |
Alcon Research, Ltd. |
Multi-layer heat assembly for a drug delivery device
|
|
JP5937004B2
(ja)
*
|
2009-05-18 |
2016-06-22 |
ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ |
薬剤溶出眼内インプラント
|
|
US12478503B2
(en)
|
2009-05-18 |
2025-11-25 |
Glaukos Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US10206813B2
(en)
|
2009-05-18 |
2019-02-19 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
WO2015073571A1
(en)
*
|
2013-11-15 |
2015-05-21 |
Dose Medical Corporation |
Ocular implants configured to store and release stable drug formulations
|
|
AU2010256558B2
(en)
|
2009-06-03 |
2013-10-03 |
Forsight Labs, Llc |
Anterior segment drug delivery
|
|
IN2012DN00352A
(de)
|
2009-06-16 |
2015-08-21 |
Bikam Pharmaceuticals Inc |
|
|
US8506532B2
(en)
|
2009-08-26 |
2013-08-13 |
Allergan, Inc. |
System including access port and applicator tool
|
|
US8708979B2
(en)
|
2009-08-26 |
2014-04-29 |
Apollo Endosurgery, Inc. |
Implantable coupling device
|
|
US8715158B2
(en)
|
2009-08-26 |
2014-05-06 |
Apollo Endosurgery, Inc. |
Implantable bottom exit port
|
|
US20120232102A1
(en)
|
2009-09-30 |
2012-09-13 |
Chun-Fang Xu |
Methods Of Administration And Treatment
|
|
WO2011069155A1
(en)
*
|
2009-12-04 |
2011-06-09 |
Opko Ophthalmics, Llc |
Compositions and methods for inhibition of vegf
|
|
US8177747B2
(en)
*
|
2009-12-22 |
2012-05-15 |
Alcon Research, Ltd. |
Method and apparatus for drug delivery
|
|
WO2011079232A1
(en)
*
|
2009-12-23 |
2011-06-30 |
Psivida Us, Inc. |
Sustained release delivery devices
|
|
US10166142B2
(en)
|
2010-01-29 |
2019-01-01 |
Forsight Vision4, Inc. |
Small molecule delivery with implantable therapeutic device
|
|
US20110189174A1
(en)
*
|
2010-02-01 |
2011-08-04 |
Afshin Shafiee |
Compositions and methods for treating, reducing, ameliorating, alleviating, or inhibiting progression of, pathogenic ocular neovascularization
|
|
US8882728B2
(en)
|
2010-02-10 |
2014-11-11 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US20110270025A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Remotely powered remotely adjustable gastric band system
|
|
US8992415B2
(en)
|
2010-04-30 |
2015-03-31 |
Apollo Endosurgery, Inc. |
Implantable device to protect tubing from puncture
|
|
US20110270021A1
(en)
|
2010-04-30 |
2011-11-03 |
Allergan, Inc. |
Electronically enhanced access port for a fluid filled implant
|
|
JP2013526572A
(ja)
*
|
2010-05-17 |
2013-06-24 |
アエリエ・ファーマシューティカルズ・インコーポレーテッド |
眼治療薬の送達のための薬物送達装置
|
|
EP2585057B1
(de)
|
2010-06-25 |
2017-08-23 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Behandlungsverfahren mit sterculiasäure
|
|
CN103209664A
(zh)
|
2010-08-05 |
2013-07-17 |
弗赛特影像4股份有限公司 |
可植入的治疗装置
|
|
WO2012019136A2
(en)
|
2010-08-05 |
2012-02-09 |
Forsight Vision 4, Inc. |
Injector apparatus and method for drug delivery
|
|
CN103153316B
(zh)
|
2010-08-05 |
2015-08-19 |
弗赛特影像4股份有限公司 |
组合药物递送方法和设备
|
|
US20120041258A1
(en)
|
2010-08-16 |
2012-02-16 |
Allergan, Inc. |
Implantable access port system
|
|
US20120065460A1
(en)
|
2010-09-14 |
2012-03-15 |
Greg Nitka |
Implantable access port system
|
|
AU2011329656B2
(en)
|
2010-11-19 |
2017-01-05 |
Forsight Vision4, Inc. |
Therapeutic agent formulations for implanted devices
|
|
US9668915B2
(en)
|
2010-11-24 |
2017-06-06 |
Dose Medical Corporation |
Drug eluting ocular implant
|
|
WO2012080833A2
(en)
|
2010-12-13 |
2012-06-21 |
Purdue Pharma L.P. |
Controlled release dosage forms
|
|
US8821373B2
(en)
|
2011-05-10 |
2014-09-02 |
Apollo Endosurgery, Inc. |
Directionless (orientation independent) needle injection port
|
|
US20120316199A1
(en)
|
2011-06-07 |
2012-12-13 |
Ward Keith W |
Compositions and methods for treating, controlling, reducing, or ameliorating inflammatory pain
|
|
US10245178B1
(en)
|
2011-06-07 |
2019-04-02 |
Glaukos Corporation |
Anterior chamber drug-eluting ocular implant
|
|
US9133082B2
(en)
|
2011-06-14 |
2015-09-15 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
EP2726016B1
(de)
|
2011-06-28 |
2023-07-19 |
ForSight Vision4, Inc. |
Vorrichtung zum sammeln einer flüssigkeitsprobe aus einer reservoirkammer einer therapeutischen vorrichtung für das auge
|
|
US8801597B2
(en)
|
2011-08-25 |
2014-08-12 |
Apollo Endosurgery, Inc. |
Implantable access port with mesh attachment rivets
|
|
US9974685B2
(en)
|
2011-08-29 |
2018-05-22 |
Mati Therapeutics |
Drug delivery system and methods of treating open angle glaucoma and ocular hypertension
|
|
ES2727203T3
(es)
|
2011-08-29 |
2019-10-14 |
Mati Therapeutics Inc |
Administración por liberación sostenida de agentes activos para tratar glaucoma e hipertensión ocular
|
|
RU2740680C2
(ru)
|
2011-09-14 |
2021-01-19 |
Форсайт Вижн5, Инк. |
Глазное вкладочное устройство и способы
|
|
SI2755600T1
(sl)
|
2011-09-16 |
2021-08-31 |
Forsight Vision4, Inc. |
Naprava za izmenjavo tekočine
|
|
WO2013058809A1
(en)
|
2011-10-19 |
2013-04-25 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
US9199069B2
(en)
|
2011-10-20 |
2015-12-01 |
Apollo Endosurgery, Inc. |
Implantable injection port
|
|
US8858421B2
(en)
|
2011-11-15 |
2014-10-14 |
Apollo Endosurgery, Inc. |
Interior needle stick guard stems for tubes
|
|
US9089395B2
(en)
|
2011-11-16 |
2015-07-28 |
Appolo Endosurgery, Inc. |
Pre-loaded septum for use with an access port
|
|
WO2013082000A1
(en)
|
2011-11-30 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
WO2013081642A1
(en)
|
2011-12-01 |
2013-06-06 |
Bikam Pharmaceuticals, Inc. |
Opsin-binding ligands, compositions and methods of use
|
|
JP6301263B2
(ja)
|
2011-12-23 |
2018-03-28 |
デピュイ・シンセス・プロダクツ・インコーポレイテッド |
ヒト臍帯組織由来細胞の検出
|
|
JP6270739B2
(ja)
|
2012-01-24 |
2018-01-31 |
ザ リージェンツ オブ ザ ユニバーシティ オブ コロラド, ア ボディー コーポレイトTHE REGENTS OF THE UNIVERSITY OF COLORADO, a body corporate |
モジュール式眼内レンズの設計および方法
|
|
US10028824B2
(en)
|
2012-01-24 |
2018-07-24 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10080648B2
(en)
|
2012-01-24 |
2018-09-25 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US9364316B1
(en)
*
|
2012-01-24 |
2016-06-14 |
Clarvista Medical, Inc. |
Modular intraocular lens designs, tools and methods
|
|
US10010448B2
(en)
|
2012-02-03 |
2018-07-03 |
Forsight Vision4, Inc. |
Insertion and removal methods and apparatus for therapeutic devices
|
|
KR101969594B1
(ko)
*
|
2012-05-11 |
2019-04-16 |
서강대학교산학협력단 |
안내 약물 전달 임플란트
|
|
EP2911623B1
(de)
|
2012-10-26 |
2019-08-14 |
Forsight Vision5, Inc. |
Ophthalmisches system für die verzögerte freisetzung von arzneimitteln ins auge
|
|
AU2014249045A1
(en)
|
2013-03-11 |
2015-10-29 |
University Of Florida Research Foundation, Inc. |
Delivery of CARD protein as therapy for occular inflammation
|
|
AU2014236455B2
(en)
|
2013-03-14 |
2018-07-12 |
Forsight Vision4, Inc. |
Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
|
|
US10517759B2
(en)
|
2013-03-15 |
2019-12-31 |
Glaukos Corporation |
Glaucoma stent and methods thereof for glaucoma treatment
|
|
AU2014241163B2
(en)
|
2013-03-28 |
2018-09-27 |
Forsight Vision4, Inc. |
Ophthalmic implant for delivering therapeutic substances
|
|
US10098836B2
(en)
|
2013-05-02 |
2018-10-16 |
Retina Foundation Of The Southwest |
Method for forming a molded two-layer ocular implant
|
|
MA39111A1
(fr)
*
|
2013-11-14 |
2017-04-28 |
Eyed Pharma |
Dispositif oculaire
|
|
AU2015219461B2
(en)
|
2014-02-18 |
2019-10-31 |
Alcon Inc. |
Modular intraocular lens designs, tools and methods
|
|
US20150342875A1
(en)
|
2014-05-29 |
2015-12-03 |
Dose Medical Corporation |
Implants with controlled drug delivery features and methods of using same
|
|
US9580896B2
(en)
|
2014-07-05 |
2017-02-28 |
John David Hopkins |
Apparatus and method for prolonged active agent in aqueous systems
|
|
RU2695563C2
(ru)
|
2014-07-15 |
2019-07-24 |
Форсайт Вижн4, Инк. |
Способ и устройство для доставки глазного имплантата
|
|
MY182793A
(en)
|
2014-08-08 |
2021-02-05 |
Forsight Vision4 Inc |
Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
|
|
JP7037360B2
(ja)
|
2014-11-10 |
2022-03-16 |
フォーサイト・ビジョン フォー・インコーポレーテッド |
拡張可能な薬物送達デバイス
|
|
ES3023708T3
(en)
|
2015-01-30 |
2025-06-03 |
Alcon Inc |
Inserter for inserting a base and a lens of a modular intraocular lens into an eye
|
|
US20160296532A1
(en)
|
2015-04-13 |
2016-10-13 |
Forsight Vision5, Inc. |
Ocular Insert Composition of a Semi-Crystalline or Crystalline Pharmaceutically Active Agent
|
|
WO2017040853A1
(en)
|
2015-09-02 |
2017-03-09 |
Glaukos Corporation |
Drug delivery implants with bi-directional delivery capacity
|
|
WO2017053885A1
(en)
|
2015-09-25 |
2017-03-30 |
Glaukos Corporation |
Punctal implants with controlled drug delivery features and methods of using same
|
|
WO2017062770A1
(en)
|
2015-10-08 |
2017-04-13 |
Silverberg Noah |
Punctal plug and bioadhesives
|
|
CA3002085A1
(en)
|
2015-11-04 |
2017-05-11 |
The Regents Of The University Of Colorado, A Body Corporate |
Modular intraocular lens designs, tools and methods
|
|
KR20180084104A
(ko)
|
2015-11-20 |
2018-07-24 |
포사이트 비젼4, 인크. |
연장 방출 약물 전달 장치를 위한 다공성 구조물
|
|
BR112018070383A2
(pt)
|
2016-04-05 |
2019-02-05 |
Forsight Vision4 Inc |
dispositivos para aplicação de fármaco oculares implantáveis
|
|
US11318043B2
(en)
|
2016-04-20 |
2022-05-03 |
Dose Medical Corporation |
Bioresorbable ocular drug delivery device
|
|
US11045309B2
(en)
|
2016-05-05 |
2021-06-29 |
The Regents Of The University Of Colorado |
Intraocular lens designs for improved stability
|
|
US20180015129A1
(en)
|
2016-07-05 |
2018-01-18 |
Janssen Biotech, Inc. |
Treatment of retinal vascular disease using progenitor cells
|
|
EP4537830A3
(de)
|
2017-06-13 |
2025-06-11 |
EyePoint Pharmaceuticals, Inc. |
Bioerodierbare arzneimittelabgabevorrichtungen
|
|
US11382736B2
(en)
|
2017-06-27 |
2022-07-12 |
Alcon Inc. |
Injector, intraocular lens system, and related methods
|
|
US11103460B2
(en)
|
2017-08-07 |
2021-08-31 |
Board Of Regents, The University Of Texas System |
Fabrication methods for nanodelivery systems for long term controlled delivery of active pharmaceutical ingredients
|
|
CN115607358A
(zh)
|
2017-11-21 |
2023-01-17 |
弗赛特影像4股份有限公司 |
用于可扩展端口递送系统的流体交换装置及使用方法
|
|
WO2019226519A1
(en)
|
2018-05-24 |
2019-11-28 |
Celanese EVA Performance Polymers Corporation |
Implantable device for sustained release of a macromolecular drug compound
|
|
WO2019222856A1
(en)
|
2018-05-24 |
2019-11-28 |
Nureva Inc. |
Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
|
|
AU2019275406B2
(en)
|
2018-05-24 |
2024-11-14 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
|
US11779739B2
(en)
*
|
2018-12-21 |
2023-10-10 |
Perfect Ip, Llc |
Drug delivery system and method
|
|
US12491264B2
(en)
|
2019-03-04 |
2025-12-09 |
Duke University |
Compositions and methods for the diagnosis and treatment of retinopathies
|
|
WO2021158968A1
(en)
|
2020-02-06 |
2021-08-12 |
Ocular Therapeutix, Inc. |
Compositions and methods for treating ocular diseases
|
|
AU2021225926A1
(en)
|
2020-02-26 |
2022-10-20 |
Case Western Reserve University |
Compositions and methods for treating misfolded protein ocular disorders
|
|
PT3884929T
(pt)
|
2020-03-25 |
2023-08-09 |
Ocular Therapeutix Inc |
Implante ocular contendo um inibidor da tirosina cinase
|
|
CA3177005A1
(en)
|
2020-04-27 |
2021-11-04 |
Michael Goldstein |
Methods of treating allergic conjunctivitis
|
|
KR102893953B1
(ko)
|
2020-09-24 |
2025-12-02 |
오큘라 테라퓨틱스, 인코포레이티드 |
하이드로겔 및 사이클로스포린을 포함하는 지속 방출 생분해성 소관내 삽입체
|
|
JP2023542939A
(ja)
|
2020-09-24 |
2023-10-12 |
オキュラ セラピューティクス，インコーポレイテッド |
ヒドロゲル及び活性薬剤を含む徐放性生分解性小管内挿入物
|
|
WO2022231930A1
(en)
|
2021-04-26 |
2022-11-03 |
Celanese Eva Performance Polymers Llc |
Implantable device for sustained release of a macromolecular drug compound
|
|
US11357620B1
(en)
|
2021-09-10 |
2022-06-14 |
California LASIK & Eye, Inc. |
Exchangeable optics and therapeutics
|
|
USD1033637S1
(en)
|
2022-01-24 |
2024-07-02 |
Forsight Vision4, Inc. |
Fluid exchange device
|
|
AU2024251447A1
(en)
|
2023-04-11 |
2025-08-21 |
Ocular Therapeutix, Inc. |
Ocular implant comprising axitinib polymorph iv
|